Omnipod® 5 with Dexcom Integration
Insulet and Dexcom are proud partners providing continued care in automated insulin delivery to our Podder® and Warrior communities.
Omnipod 5 is compatible with Dexcom G7 and Dexcom G7 15 Day
The first tubeless automated insulin delivery system, integrated with both Dexcom G7 CGM Systems, keeps you in automated mode longer with on-body functionality and faster CGM sensor warm-up times.†
If you use Omnipod 5, you don't need to change your current Pod prescription to switch between Dexcom CGM Systems. Learn more here about Pod compatibility.
Omnipod® 5 + CGM sensors:
Smart insulin delivery, made simple
Omnipod 5 is an automated insulin delivery (AID system designed to simplify insulin delivery for your personal needs. When paired with a compatible continuous glucose monitor (CGM) like Dexcom G7 15 Day (ages 18+) or Dexcom G7 (ages 2+), Omnipod 5 adjusts insulin delivery based on current and predicted glucose values.
The Pod receives an updated sensor glucose value and trend and automatically adjusts insulin delivery every 5 minutes, and helps keep you in range1-3 without constant manual input.
Whether you're looking for simplicity, discretion, or control, Omnipod 5 with integrated CGM support brings everything together in one seamless experience.
Get to know each system:
Omnipod 5 with Dexcom G7 15 Day
Omnipod 5 with Dexcom G7
Learn more about Dexcom G7 CGM Systems on Dexcom's website.
Dexcom is in the process of discontinuing Dexcom G6 to focus on delivering the next generation of CGM. Omnipod 5 will continue to support integration with Dexcom G6 for as long as this sensor remains available. For more information, please visit www.dexcom.com or contact Dexcom support.
Get started with Omnipod 5
Interested in a complimentary benefits check? Click below to learn more.
Video Tutorials
Frequently Asked Questions
How can I tell if my Omnipod® 5 Pods are compatible with Dexcom G7 CGM Systems and Dexcom G6?
How do I pair my Dexcom G7 CGM Systems sensor with my Omnipod 5 System?
How do I pair Dexcom G6 with the Omnipod 5 System?
Explore Omnipod 5 FAQs: Omnipod 5 with Dexcom CGM sensors for more information.
*A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. In other words, when using the product per the package labeling, approximately 26% of sensors may not last for the full 15 days.
**Separate Follow app and internet connection required
†More time in automated mode based on up to 60 min warm up time for Dexcom G7 CGM Systems versus 2 hours with Dexcom G6. During sensor warm up the system enters Automated Mode: Limited. The Dexcom G7 15-Day CGM is indicated for adults (18+) and Omnipod 5 users can use the 15-day CGM with the Dexcom G7 receiver or app, while standard G7 Omnipod 5 users can only use the Dexcom G7 app.
†† More time in automated mode based on 30 min warm up time for Dexcom G7 versus 2 hours with Dexcom G6. During sensor warm up the system enters Automated Mode: Limited.
Note: Sensor sold separately, requires a separate prescription. Dexcom G6 and Dexcom G7 must be used with the Dexcom mobile app to use Automated Mode. The Dexcom receiver is not compatible with these configurations of the Omnipod 5 system.
The Dexcom G7 15 Day is indicated for ages 18+ and the Dexcom G7 is indicated for ages 2+.
1. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 in adults/adolescents and children = 64.7% vs. 73.9%; 52.5% vs. 68.0%. Study funded by Insulet.
2. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. Study funded by Insulet.
3. Pasquel FJ, et al. JAMA Network Open (2025). Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. Mean time in range (70-180 mg/dL): ST vs. 13-week Omnipod 5: 45% vs. 66%, P<0.001.
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Admelog®, and Kirsty®.
Refer to the Omnipod® 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia. Warning: do not use SmartAdjust technology in persons under 2 years of age or who use less than 5U of insulin per day.
Available products subject to current insurance coverage and product indication for use. Insulet can only support onboarding for those customers within the product indication.
